The Notch signal pathway plays important roles in proliferation, apoptosis, and differentiation. Abnormalities in Notch signaling are linked to many human diseases. After ligand binding, Notch signaling is activated through the cleavage of Notch receptors to release and translocate the Notch intracellular domain into the nucleus. The Notch1 receptor intracellular domain (N1IC), the activated form of the Notch1 receptor, can modulate downstream target genes via C promoter-binding factor 1-dependent and -independent pathways. To further dissect the Notch1 signaling pathway, we screened the N1IC-associated proteins using a yeast two-hybrid system and identified nuclear ␤ II -tubulin as a candidate for the N1IC-associated proteins. It was suggested that the presence of ␤ IItubulin in nuclei might be correlated with the cancerous state of cells. However, the function of ␤ II -tubulin locating in the nucleus still is unknown. Herein, we show that the complex of ␣-and ␤ II -tubulin is associated with N1IC in cancer cells by a coimmunoprecipitation analysis. The ankyrin domain of the Notch1 receptor alone was sufficient to associate with ␤ II -tubulin. Furthermore, ␣-and ␤ II -tubulin were localized in the nucleus and formed a complex with N1IC. Treatment with Taxol increased the amounts of nuclear ␣-and ␤ II -tubulin in K562 and HeLa cells and promoted the C promoter-binding factor 1-dependent transactivation activity of N1IC. We also show that nuclear ␤ II -tubulin was bound on the C promoter-binding factor 1 response elements via the association with N1IC. These results suggest that nuclear ␤ II -tubulin can modulate Notch signaling through interaction with N1IC in cancer cells.
INTRODUCTION
Genes of Notch receptors encode evolutionarily conserved transmembrane receptors to regulate cell fate decisions during development (1) . Many reports have documented that the Notch signal pathway modulates proliferation, apoptosis, and differentiation (1) (2) (3) . Notch signaling also has been implicated in human cancers and in cancers induced by retroviral insertions in mice (4, 5) . The Notch intracellular domain, the activated form of the Notch receptor, may function as an oncogene or tumor suppressor to promote or suppress tumorigenesis (for a review, see ref. 6 ). The effects of Notch signaling are cell type dependent, and these pathways that mediate growth and transformation may proceed through cross-talk with other signal pathways, such as transforming growth factor ␤ (7) and epidermal growth factor receptor-mitogen-activated protein kinase signaling pathways (8) .
After ligand binding, Notch signaling is activated through cleavage of Notch receptors, which allows the release and translocation of the Notch intracellular domain into the nucleus. The Notch intracellular domain modulates downstream target genes via C promoter-binding factor 1 (CBF1)-dependent and -independent pathways (9) .
A few Notch1 intracellular domain (N1IC)-associated cellular factors have been found, and we recently also reported the association of transcription factor Yin Yang 1 (YY1) with N1IC (10) . Only few downstream target genes of N1IC have been identified, such as the HES family (11) , Nrarp (12), HERP2 (13) , cyclin D1 (14) , activator protein (15) , the pre-T-cell receptor ␣ (pT␣) gene (16) , and acid ␣-glucosidase (17) . However, the mechanisms controlling Notch1 signaling remain poorly understood.
To further dissect the Notch1 signaling pathway, we used a yeast two-hybrid system to search the N1IC-associated proteins and found nuclear ␤ II -tubulin as one of the candidates. ␤-Tubulin is one of the structural subunits of microtubules, which consists of the heterodimer of ␣-and ␤-tubulin. In most normal cells, tubulin resides only in the cytosol and not in the nucleus. Although the existence of nuclear ␤ II -tubulin could not be detected in biopsy samples of normal human tissues (18) , the ␤ II isotype of tubulin recently was found in the nuclei of several tumor cells (19 -21) . These observations suggest that the presence of nuclear ␤ II -tubulin may be correlated with the cancerous state of cells (20) .
Taxol, an antitumor drug, exhibits higher specificity for ␤ II -tubulin than for other isotypes. In a concentration-caused cellular apoptosis, Taxol could irreversibly deplete the nuclear ␤ II -tubulin content in rat C6 glioma cells (20) . Nuclear ␤ II -tubulin was found to exist as ␣␤ II dimers instead of assembled microtubules (19) . However, the biological function of ␤ II -tubulin locating in nuclei still is unknown. In this study, we show that the association of nuclear ␤ II -tubulin with N1IC can modulate CBF1-dependent gene expression. (10) . Taxol (Sigma-Aldrich, St. Louis, MO) at indicated concentrations in dimethyl sulfoxide or an equal volume of dimethyl sulfoxide was added for 24 hours, followed by washing with PBS three times and further incubated in the absence of Taxol for 24 hours or 48 hours. Cycloheximide (Sigma-Aldrich) was used at 25 g/mL. For transient transfection of the luciferase reporter assay, K562 cells or HeLa cells (1 ϫ 10 6 ) were seeded onto six-well plates and transfected using the SuperFect transfection reagent (Qiagen, Valencia, CA), and luciferase activities were measured as described previously (10) .
For chromatin immunoprecipitation (ChIP) experiments, the K562/HA-N1IC cells (5 ϫ 10 6 ) were transfected with 5 g of reporter plasmids 4ϫwtCBF1Luc; cells were harvested 24 hours after transfection.
Coimmunoprecipitation. To prepare whole-cell lysates, cells were lysed in NETN buffer [50 mmol/L Tris-HCl (pH 7.9), 150 mmol/L NaCl, 0.5 mmol/L EDTA, and 0.5% NP40] containing protease and phosphatase inhibitors (1 mmol/L phenylmethylsulfonyl fluoride, 10 g/mL aprotinin, 10 g/mL leupeptin, and 100 mmol/L sodium fluoride). Two alternative buffers, buffer A [20 mmol/L HEPES (pH 7.4), 150 mmol/L NaCl, 2 mmol/L MgSO 4 , and 0.5% NP40] and buffer B (PBS containing 0.5% NP40), containing protease and phosphatase inhibitors also were used as indicated. Cell lysates briefly were centrifuged to remove cell debris and then immunoprecipitated with protein A-Sepharose-bound anti-␤ II -tubulin antibody (Sigma-Aldrich) as described previously (10) . Western blot analysis was performed with antiNotch1 COOH-terminal (Santa Cruz Biotechnology, Santa Cruz, CA), anti-␤ II -tubulin, and anti-␣-tubulin antibodies (Santa Cruz Biotechnology).
Glutathione S-Transferase Pull-Down Assay. N1IC proteins expressed as GST-ANK⌬EP and GST-ANK fusion proteins from the expression constructs of pGST-ANK⌬EP and pGST-ANK were induced and purified as described previously (10) . Whole-cell extracts of K562/HA-N1IC cells were prepared in NETN buffer as described previously. A 50% (v/v) slurry of glutathione-agarose resin prebound with 0.5 g of GST or GST fusion proteins was incubated with 500 g of whole-cell extracts for the pull-down assay at 4°C for 2 hours as described elsewhere (10) . Subcellular Fractionation and Sucrose Gradient Analysis. To prepare the nuclear extracts, cell pellets were suspended and lysed in a hypotonic buffer; after centrifugation, the nuclear pellets were resuspended in a high-salt buffer as described previously (10) . Nuclear extracts of K562/HA-N1IC or K562/pcDNA3 cells were loaded on the top of a 10% to 60% (w/v) sucrose gradient for centrifugation (10) . The gradients were fractionated into 0.5-mL fractions each from the top, and aliquots of each fraction were subjected to Western blot analysis to detect ␤ II -tubulin and N1IC proteins. We also prepared the protein standards (catalase, 11.3 S, M r 232,000; thyroglobulin, 19.4 S, M r 669,000) to be run on a sucrose gradient.
Oligoprecipitation and Chromatin Immunoprecipitation. The 5Ј-biotinylated oligonucleotides and the protocol for oligoprecipitation were as described by Yeh et al. (10) . The procedure for ChIP of K562/HA-N1IC cells transfected with luciferase reporter plasmids using protein A-Sepharose-bound anti-␤ II -tubulin antibody and the specific primers for PCR amplification also was described previously (10) .
RESULTS
␤ II -Tubulin Is a Candidate of Notch1 Receptor Intracellular Domain-Associated Proteins. To date, molecular mechanisms regulating the Notch signal pathway remain obscure. To understand the Notch1 signaling pathway, we used the yeast two-hybrid system to search the protein(s) that interact with the activated Notch1 receptor (N1IC). The truncated fragment of N1IC, ANK⌬EP (23), was expressed to screen N1IC-associated cellular factors from a human testis cDNA library in the presence of 3-amino-1,2,4-triazole. The cytoskeletal protein ␤ II -tubulin was one of the candidates for the N1IC-associated proteins. The COOH-terminal region of ␤ II -tubulin (accession no. BC019829) encompassing amino acid residues from 197 to 445 was identified as the region associated with the ANK domain of the Notch1 receptor (ANK⌬EP) in the yeast two-hybrid system (data not shown).
The Notch1 Receptor Intracellular Domain Associates with ␤ II -Tubulin in Cancer Cells. To confirm the association of N1IC with ␤ II -tubulin in cancer cells, whole-cell extracts of K562 cells (K562/pcDNA3), HA-N1IC protein-expressing K562 cells (K562/ HA-N1IC), and SUP-T1 cells were used for coimmunoprecipitation by antimouse IgG or anti-␤ II -tubulin antibodies ( Fig. 1A and B) . The HA-N1IC fusion protein was coimmunoprecipitated with ␤ II -tubulin in K562/HA-N1IC and SUP-T1 cells by anti-␤ II -tubulin antibody. This interaction between ␤ II -tubulin and N1IC also was observed in Jurkat cells using anti-Notch1 COOH-terminal antibody for immunoprecipitation (data not shown). ␣-Tubulin also was coimmunoprecipitated with ␤ II -tubulin; this might be because of the nuclear ␤ II -tubulin existing as ␣␤ II dimers (19) .
To avoid the binding artifacts generated by the denaturation of tubulins, either HEPES buffer (buffer A) or PBS (buffer B) also was used for the coimmunoprecipitation instead of NETN buffer. The interaction between ␤ II -tubulin and N1IC also was found in K562/ HA-N1IC cells (Fig. 1C) . Therefore, these results suggest that the Notch1 receptor intracellular domain associated with the heterodimer form of ␣-and ␤ II -tubulin in cells.
The ANK Domain of the Notch1 Receptor Is Sufficient to Associate with the ␤ II -Tubulin. The in vitro GST fusion protein pull-down assay was used to dissect the region of N1IC required for the association with ␤ II -tubulin. Partially purified GST and GST fusion proteins of N1IC were analyzed by SDS-PAGE and Coomassie Blue staining (Fig. 2) . Whole-cell extracts of K562/ pcDNA3 cells were prepared for the pull-down assay by GST and GST fusion proteins. Both fusion proteins of GST-ANK⌬EP and GST-ANK were shown to associate with endogenous ␤ II -tubulin of K562/pcDNA3 cells. Therefore, the ANK domain of the Notch1 receptor alone was sufficient to associate with ␤ II -tubulin. This is consistent with the result of two-hybrid screening, in which the COOH-terminal half of ␤ II -tubulin was identified as the prey of ANK⌬EP protein.
Nuclear ␤ II -Tubulin Exists in Cancer Cells. The ␤ II isotype of tubulin was found in the nuclei of several tumor cells, including HeLa cells, and the presence of nuclear ␤ II -tubulin might be correlated with the cancerous state of cells (20) . To determine the existence of nuclear ␤ II -tubulin in the hematopoietic tumor cells, the nuclear and cytosolic extracts of K562 and SUP-T1 cells were used for Western blot analysis (Fig. 3) . ␤ II -Tubulin was present in the nuclei and the cytoplasm of K562 and SUP-T1 cells and HeLa cells. In the same blotting membranes, nucleolar B23 only was detected in the nuclear fractions, whereas glyceraldehyde-3-phosphate dehydrogenase only was observed in cytosolic fractions. Therefore, the existence of nuclear ␤ II -tubulin from the possibility of contamination of cytosolic proteins in the nuclear extracts of these cells could be excluded.
The Intrinsic Activated Notch1 Receptor Associates with Endogenous ␤ II -Tubulin in Nuclear Complexes. The Notch1 receptor intracellular domain previously had been shown to form a high molecular weight complex with cellular factors in the nuclei (10, 24) . To gain further insights into the physiology of the interaction between N1IC and ␤ II -tubulin, their distributions in nuclei were investigated by sucrose gradient analysis. The nuclear extracts of K562/pcDNA3-and HA-N1IC-expressing K562/HA-N1IC cells were prepared for sucrose gradient ultracentrifugation. The collected fractions were analyzed by Western blot analysis using anti-Notch1 COOH-terminal and anti-␤ II -tubulin antibodies sequentially. The sucrose gradient analysis profile showed that N1IC existed in both lower molecular weight fractions (fractions 3 to 7) and higher molecular weight fractions (fractions 14 to 16; Fig. 4A ), whereas ␤ II -tubulin was detected in fractions 2 to 15. In the absence of the activated Notch1 receptor (i.e., K562/pcDNA3 cells), ␤ II -tubulin showed the same sucrose gradient profile as that of K562/HA-N1IC cells.
To confirm the association between N1IC and nuclear ␤ II -tubulin, coimmunoprecipitation was applied to the nuclear extracts of K562/ pcDNA3 and stable N1IC-expressing K562/HA-N1IC cells. ␤ II -tubulin was immunoprecipitated in the nuclear fractions of these two cells using anti-␤ II -tubulin antibody (Fig. 4B) . After stripping and reprobing this immunoprecipitated blot, N1IC, but not transcription factor YY1, also was detected in the nuclear fraction of K562/HA-N1IC cells. Furthermore, ␣-tubulin also was coimmunoprecipitated in this analysis, presumably through association with ␤ II -tubulin. These results showed that ectopically expressed N1IC was associated with endogenous ␤ II -tubulin in nuclei by the analysis of coimmunoprecipitation.
To check whether intrinsic N1IC interacts with endogenous ␤ IItubulin in the nuclei of cancer cells, nuclear extracts of SUP-T1 cells were prepared for coimmunoprecipitation using the anti-␤ II -tubulin antibody. Fig. 4B shows that N1IC could be coimmunoprecipitated with ␤ II -tubulin in the nuclei of SUP-T1 cells. This N1IC-␤ II -tubulin association also was found in nuclei of HeLa cells (data not shown).
Contents of Nuclear ␣-and ␤ II -Tubulin Were Elevated by Nonapoptotic Concentrations of Taxol in Cancer Cells. To evaluate the effect of Taxol on ␤ II -tubulin, nuclear and cytosolic extracts of K562 and HeLa cells were prepared for Western blot analysis after treatment with Taxol for 24 hours. The K562 cell, a human chronic myelogenous leukemia cell line, expresses Bcr-Abl, which mediated high resistance to Taxol-induced apoptosis as showed higher concentrations of Taxol (mol/L range) were used (25) . Nevertheless, Taxol at low concentrations (10 nmol/L for 20 hours) already induced mitotic block in HeLa cells by suppressing the dynamics of spindle microtubules (26) . To confirm whether Taxol inhibited the cell proliferation in these conditions, HeLa cells were treated with various concentrations of Taxol for 24 hours. As described previously (27) , cell numbers of HeLa cells were not affected in the presence of Taxol at lower concentrations (5 and 10 nmol/L; Fig. 5A ). However, the numbers of survival cells were decreased after treatment with higher concentrations of Taxol (25 and 50 nmol/L) in HeLa cells.
The Taxol-treated K562 cells showed dramatic quantity increment of ␣-and ␤ II -tubulin in the nuclei without affecting both contents in the cytosol (Fig. 5B) . Furthermore, the amounts of nuclear ␣-and ␤ II -tubulin also were elevated without affecting cytosolic counterparts apparently in Taxol-treated HeLa cells (Fig. 5C ). Previous treatment of HeLa cells with cycloheximide did not affect the increment of nuclear tubulins by Taxol. Therefore, this phenomenon was not because of de novo protein synthesis. This increase of nuclear ␤ IItubulin induced by Taxol was sustained within 2 days after the removal of Taxol (Fig. 5D) . However, the effect on the augmentation of nuclear tubulins was not observed in the presence of colchicine, an Fig. 2 . ANK domain of the Notch1 receptor is sufficient to associate with ␤ II -tubulin. Whole-cell extracts of K562/pcDNA3 cells were used for the pull-down assay with purified GST, GST-ANK⌬EP, and GST-ANK fusion proteins. The pull-down pellets were resolved by SDS-PAGE and analyzed by Western blot analysis using anti-␤ II -tubulin antibody (bottom). The same amounts of inputs of various GST fusion proteins were resolved by SDS-PAGE and analyzed by Coomassie Blue (CB) staining (top). antimicrotubule agent (data not shown). Analyzing using confocal microscopy, the nuclear ␤ II -tubulin was increased in K562/HA-N1IC cells and colocalized with N1IC in nucleus after treatment with 3.5 mol/L Taxol for 24 hours (data not shown). These results suggest that Taxol may increase the nuclear import of ␣-and ␤ II -tubulin in K562 and HeLa cells.
Enhancement of Luciferase Reporter Activity Transactivated by the Notch1 Receptor Intracellular Domain after Treatment with Taxol.
To elucidate the biological function of the association between N1IC and nuclear ␤ II -tubulin in the Notch signaling pathway, a luciferase reporter assay was performed. K562 cells were cotransfected with a luciferase reporter plasmid containing four copies of wild-type CBF1 response elements (4ϫwtCBF1Luc) and an N1IC-expressing construct, pcDNA3-HA-N1IC, or their control vectors in the presence of various concentrations of Taxol. The transfected cells were harvested and assayed for luciferase activity 24 hours after transfection. Although Taxol had been shown to alter gene expression (28 -30) , it did not affect the activity of the luciferase reporter gene containing CBF1 response elements (Fig. 6A) . In the absence of Taxol, N1IC enhanced the expression of the reporter gene containing CBF1 response elements by ϳ12-fold in K562 cells. This promotion of luciferase activity was further elevated ϳ1.5-and 4-fold in the presence of 3.5 and 7 mol/L Taxol, respectively. Enhancement of luciferase activity of approximately twofold to threefold by Taxol also was observed in HeLa cells (Fig. 6B ). These effects of Taxol were not detected in the luciferase reporter plasmid containing four copies of the mutant CBF1 response elements (4ϫmtCBF1Luc) in either cell line (data not shown). Moreover, the activation of CBF1-dependent luciferase reporter activity in K562 cells and HeLa cells was not observed in the presence of colchicine (data not shown). These results imply that Taxol augments the CBF1-dependent transactivation activity of N1IC.
The ␤ II -Tubulin-N1IC-Associated Complex Binds on the WildType CBF1 Response Element, but not on the Mutant One. The aforementioned data show that Taxol treatment increases the quantity of nuclear ␤ II -tubulin and also turns on CBF1-dependent Notch signaling in K562 and HeLa cells. We surmised that nuclear ␤ II -tubulin might participate in modulation of the Notch signal pathway. Therefore, oligoprecipitation was performed to study the interaction between the ␤ II -tubulin-N1IC-associated complex and the CBF1 recognition DNA sequence. In K562/HA-N1IC cells, N1IC and ␤ II -tubulin could be precipitated, together with the 5Ј-biotinylated wild-type CBF1 response element, by streptavidinagarose beads but not with the mutant one (Fig. 6C) . Furthermore, the ChIP assay also was used to examine the specific association of ␤ II -tubulin and N1IC with targeted DNA sequence in the context of living cells. K562/HA-N1IC cells were transiently transfected with reporter plasmid 4ϫwtCBF1Luc. Twenty-four hours after transfection, the cells were treated with formaldehyde to cross-link DNA and protein and then harvested for the ChIP assay using anti-His and anti-␤ II -tubulin antibodies. The amplified PCR product of 470 bp was only present in the sample immunoprecipitated by anti-␤ II -tubulin antibody (Fig. 6D) . These data imply that nuclear ␤ II -tubulin indirectly binds on the wild-type CBF1 response element via associating with N1IC, which directly interacts with CBF1, and this association may enhance the transactivation activity of N1IC.
DISCUSSION
The role and regulation of Notch signal pathway are complicated and not yet fully understood. Notch signaling integrates with several other signal pathways during development. Many of these integrations are cell-type and -context dependent, suggesting that these are either directly or indirectly modulated by cell-specific cofactors. The activated Notch1 receptor recently was shown to form a high molecular weight complex containing Mastermind-like 1, CBF1, and transcription factor YY1 in the nucleus (10, 24) . These associations modulate the transactivation activity of N1IC in regulating the Notch signal pathway.
In this study, we identified ␤ II -tubulin as an N1IC-associated protein, and this association modulates Notch signaling. The biological function of ␤ II -tubulin locating in nucleus still is unclear, although it was suggested that nuclear ␤ II -tubulin might be corre- Fig. 6 . CBF1-mediated transactivation activity of N1IC is modulated by Taxol. A and B. Reporter plasmid containing wild-type CBF1 response elements was cotransfected with HA-N1IC protein-expressing plasmid or its control vector into K562 cells (A) or HeLa cells (B) in the presence of various concentrations of Taxol. After 24 hours, luciferase activity was determined from whole-cell extracts, and the basal promoter activity of the reporter construct was set to unity. Mean values and SDs from at least four independent experiments are shown. C. The ␤ II -tubulin-N1IC-associated complex binds on the wild-type CBF1 response element but not on the mutant one. The nuclear extract of K562/HA-N1IC cells was incubated with the 5Ј-biotinylated double-stranded oligonucleotides of wild-type (WT) or mutant (mt) CBF1 response elements and then precipitated with streptavidin-agarose beads. The precipitated proteins were resolved by SDS-PAGE and analyzed by Western blot analysis using anti-Notch1 COOH-terminal (C-ter) antibody (top) or anti-␤ II -tubulin antibody (bottom). D. K562/HA-N1IC cells were transiently transfected with reporter plasmid containing wild-type CBF1 response elements. Twenty-four hours after transfection, transfected cells were harvested for ChIP assay using anti-His and anti-␤ II -tubulin antibodies. The immunoprecipitated DNA was used to amplify a 470-bp PCR product by specific primers for the region of the CBF1 response element in the reporter plasmid. (ϩ) PCR-positive control uses 4 ng of 4ϫwtCBF1Luc plasmid as the DNA template. lated with the cancerous state of cells (20) . The relationship between the intracellular domain of the human Notch1 receptor and ␤ II -tubulin was investigated. We show herein that N1IC associated with ␤ II -tubulin in the nuclei of cancer cells and that Taxol treatment induced the increment of nuclear tubulins and increased the CBF1-dependent transactivation activity of N1IC. This is the first report regarding the involvement of nuclear ␤ II -tubulin in CBF1-dependent Notch signaling. These data suggest that nuclear ␤ II -tubulin may be involved in the control of tumorigenesis through the interaction with activated Notch1 receptor, which has been implicated in cancers (5, 6) .
It was reported that the distribution of nuclear ␤ II was highly dependent on the type of cancer (21) . These findings and our results suggest that nuclear ␤ II -tubulin could be a useful diagnostic agent in cancers. In addition to clarifying the biological function of nuclear tubulin in cancer cells, this study also raises the possibility that regulation of tumor formation could be regulated by nuclear ␤ IItubulin through Notch signaling. We will further dissect the roles of nuclear ␤ II -tubulin in tumorigenesis of various cancers.
An intriguing similar situation is that the cytoskeletal protein actin also has been detected in the cell nucleus, and it has been tentatively implicated in gene expression (31) (32) (33) (34) (35) . Percipalle et al. (36) recently also showed that the actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II.
Taxol not only binds to tubulin to promote microtubule assembly and to stabilize microtubules by bundle formation (37-39) but also to modulate gene expression (28 -30) . Furthermore, Taxol markedly enhances the nuclear factor B and activator protein transcription factors binding to their response elements in the interleukin-8 promoter, which in turn up-regulates the IL-8 gene in Taxol-responsive ovarian cancer cells (40) . To clarify whether elevation of nuclear ␤ II -tubulin by Taxol of nonapoptotic concentration was caused by activation of gene expression or nuclear translocation, cycloheximide was used to block the de novo protein synthesis. Elevation of nuclear ␤ II -tubulin by Taxol also was observed in the presence of this inhibitor ( Fig. 5B and C) . The amount of nuclear ␤ II -tubulin in the cytosolic fraction also showed no apparent variation with the various treatments. These results may exclude the possibility that Taxol activates ␤ II -tubulin gene expression and suggest that Taxol enhances the nuclear import of ␤ II -tubulin. This observation in K562 and HeLa cells is different from that of rat C6 glioma cells; Taxol in an apoptotic concentration has been shown to deplete nuclear ␤ II -tubulin in C6 glioma cells (20) .
How does ␤ II -tubulin enter nuclei of cancer cells? The COOHterminal region of tubulin is less conserved among various isotypes (41); therefore, this isotype-specific region may be involved in the nuclear entrance of ␤ II -tubulin. The nuclear ␤ II -tubulin, most likely in the form of ␣␤ II dimer, was suggested to bind with the ␤ II -interacting protein to remain itself in the nucleus (21) . In the experiment of yeast two-hybrid system, we found that the COOH-terminal region of ␤ II -tubulin (amino acid residues 197 to 445) is sufficient to associate with N1IC. It is possible that N1IC with the nuclear localization signal may be involved in the nuclear localization of ␤ II -tubulin through their association.
Alternatively, it also has been speculated that ␤ II -tubulin remains attached to chromatin after cell division and then is trapped in the nucleus during interphase (42) . However, cell cycle arrest induced by Taxol cannot enhance nuclear localization of ␤ II -tubulin through attachment to chromatin from the mitotic phase into interphase. This implies that there must be other mechanisms through which ␤ IItubulin enters the nucleus.
